Mark Milton-Edwards
Head of Product & Health Solutions - Digital Health at Teva Pharmaceuticals
Mark has worked with Swellaway Ltd. for >3yrs. in a NED role with a special focus on Digital Health Regulatory, IP and commercialisation. Mark holds a full-time role for more than 13yrs with TEVA Pharmaceuticals and over 16years with AstraZeneca prior to this. Mark has held various positions including R&D Project Leader, VP Sales & Marketing, Strategic Planning & Business Development, and Global Brand Lead. Graduated in Aeronautical Sciences and completed his MBA at Durham University, UK.
Mark has numerous patents granted and pending in electronic communications, sports technologies, inhaled pharmaceutical development, and respiratory physiological function & predictive AI. Mark is the inventor of Digihaler®, the first FDA approved digital inhaler with built-in sensors.
